Abstracts Archive - Page 1923 of 2607 - ACR Meeting Abstracts

Abstract Number: 778 • 2015 ACR/ARHP Annual Meeting
Associations Between Autoantibodies and Clinical Manifestations in Systemic Lupus Erythematosus: Data from a Multiethnic Latin American Cohort
Manuel Ugarte-Gil^1,2, Daniel Wojdyla³, Ignacio Garcia-Valladares⁴, Rocio V. Gamboa-Cardenas¹, Yelitza Gonzalez-Bello^5,6, Guillermo J. Pons-Estel⁷, Cesar A. Pastor-Asurza^1,8, Ignacio Garcia-De La Torre^9,10, Graciela S. Alarcon¹¹, Bernado Pons-Estel¹² and GLADEL (Grupo Latinoamericano de Estudio de Lupus), ¹Rheumatology, Hospital Guillermo Almenara Irigoyen. EsSalud, Lima, Peru, ²Universidad Cientifica del Sur, Lima, Peru, ³Universidad Nacional de Rosario, Argentina, Rosario, Argentina, ⁴Centro de Estudios de Investigación Básica y Clínica, SC., Guadalajara, Jalisco, Mexico, ⁵Immunology and Rheumatology, Hospital General de Occidente, Secretaria de Salud Jalisco, Guadalajara, Jalisco, Mexico, ⁶Immunology and Rheumatlogy, Universidad de Guadalajara, Zapopan, Jalisco, Mexico, ⁷Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain, ⁸Universidad Nacional Mayor de San Marcos, Lima, Peru, ⁹Immunology and Rheumatology, Hospital General de Occidente, Secretaria de Salud Jalisco, Zapopan, Jalisco, Mexico, ¹⁰Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, ¹¹Medicine, University of Alabama at Birmingham, Birmingham, AL, ¹²Hospital Provincial de Rosario, Rosario, Argentina
Background/Purpose: Analyses of the association between autoantibodies and SLE clinical manifestations using cluster analyses assume that centroid and within-cluster residuals are similar inside the cluster…
Abstract Number: 779 • 2015 ACR/ARHP Annual Meeting
Mapping Perceptions of Medication Decision Making Facilitators: The Importance of Patient Context
Haiyan Qu¹, Jinoos Yazdany², W. Winn Chatham³, Ricahrd Shewchuk⁴ and Jasvinder A. Singh¹, ¹University of Alabama at Birmingham, Birmingham, AL, ²University of California, San Francisco, San Francisco, CA, ³Medicine/Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁴University fo Alabama at Birmingham, Birmingham, AL
Background/Purpose: Our objective was to derive a cognitive map of how stakeholders perceive patient-identified facilitators to establish a theoretical framework for the purpose of developing…
Abstract Number: 780 • 2015 ACR/ARHP Annual Meeting
Long-Term Prognosis and Factors Associated with Damage Accrual in Japanese Patients with Systemic Lupus Erythematosus
Yoko Wada¹, Hisashi Hasegawa², Takeshi Kuroda³, Masaaki Nakano⁴ and Ichiei Narita¹, ¹Department of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan, ²Division of Clinical Nephrology and Rheumatology, Niigata City General Hospital, Niigata, Japan, ³Health Administration Center, Niigata University, Niigata, Japan, ⁴Department of Medical Technology, School of Health Sciences, Faculty of Medicine, Niigata University, Niigata, Japan
Background/Purpose: Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease characterized by fluctuating disease activity over periods of years. The estimated 5-year survival rate of…
Abstract Number: 781 • 2015 ACR/ARHP Annual Meeting
Anti-Nucleosome Antibodies Versus Anti-DNA Antibodies in the Diagnosis and Monitoring of Activity of Systemic Lupus Erytematosus
Helena Borrell Paños¹, Javier Narváez², Jordi Bas³, Eulàlia Armengol¹, Maria Aparicio¹, Maria Pascual¹, Mercè López de Recalde¹ and Joan Miquel Nolla¹, ¹Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, ²Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, ³Immunology Department. Hospital Universitari de Bellvitge, Barcelona, Spain
Background/Purpose: Recently, the study of anti-nucleosome antibodies (ANUCs) has been suggested that they may be useful in the diagnosis of systemic lupus erythematosus (SLE) and in…
Abstract Number: 782 • 2015 ACR/ARHP Annual Meeting
A Proposal for Assessing Systemic Lupus Erythematosus Activity By a Multimodal Instrument That Includes Clinical Variables, Physician Assessment and Modification of Treatment
Francisco Espinoza Sr.¹ and K Kalunian², ¹Rheumatology Department, Division of Internal Medicine, School of Medicine, University of Los Andes, Santiago, Chile, ²UCSD School of Medicine, La Jolla, CA
Background/Purpose: Assessment of systemic lupus erythematosus (SLE) is complex due to its heterogeneous manifestations and its fluctuant clinical course. Current instruments stressed one specific aspect…
Abstract Number: 783 • 2015 ACR/ARHP Annual Meeting
Osteonecrosis in Systemic Lupus Erythematosus: Predictive Factors
Nimrit Dhillon¹, Dafna Gladman¹, Jiandong Su¹ and Murray Urowitz^1,2, ¹Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Rheumatology, U of Toronto, Toronto Western Hospital, Toronto, ON, Canada
Background/Purpose: We recently reported the frequency of symptomatic osteonecrosis (ON) among systemic lupus erythematosus (SLE) patients of the lupus cohort to be 13.6% The aim…
Abstract Number: 784 • 2015 ACR/ARHP Annual Meeting
Electronic Health Record (EHR) As a Powerful Tool to Establish Clinical Research Lupus Cohorts
Srilatha Kothandaraman¹, Frederick Ramsey², David Fleece³, Aaron Sorenson², Lai Ping⁴, Srikanth Mukkera¹, King Goh¹ and Roberto Caricchio⁵, ¹Rheumatology, Temple University, Philadelphia, PA, ²Clinical Sciences, Temple University, Philadelphia, PA, ³Pediatrics, Temple University, Philadelphia, PA, ⁴Temple University, Philadelphia, PA, ⁵Medicine, Rheumatology, Temple University, Philadelphia, PA
Background/Purpose: Enhancing a typical EHR through implementation and utilization of research-validated instruments is termed Electronic Data Capture (EDC). EDC is found to be more efficient…
Abstract Number: 785 • 2015 ACR/ARHP Annual Meeting
Further Validation of Simple Index As a Simple Disease Activity Assessment Tool for SLE
Nisarg Gandhi¹, Meenakshi Jolly², Alana Nevares³ and Winston Sequeira¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Department of Medicine, Section of Rheumatology, Rush University Medical Center, Chicago, IL, ³Internal Medicine, Cook County Hospital, Chicago, IL
Background/Purpose: An easy, quick tool, requiring minimal training or physician input for disease activity (DA) assessment in SLE, would have potentially greater uptake for routine…
Abstract Number: 786 • 2015 ACR/ARHP Annual Meeting
Anti-Carbamylated Protein Antibodies Identify Systemic Lupus Erythematosus Patients with Erosive Arthritis: Analysis of a Regional Swedish Register
Alf Kastbom¹, Philip Wallin², Michael Ziegelasch¹, Thomas Skogh¹, Leendert Trouw³ and Christopher Sjöwall¹, ¹Department of Clinical and Experimental Medicine, Rheumatology/AIR, Linköping, Sweden, ²Linköping University, Clinical and Experimental Medicine, Sweden, Rheumatology/AIR, Linköping, Sweden, ³Rheumatology, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: Articular manifestations affect a majority of patients with systemic lupus erythematosus (SLE), at least at some time during the disease course. Several investigators have…
Abstract Number: 787 • 2015 ACR/ARHP Annual Meeting
Validation of Lupuspro V1.8, Disease Targeted Patient Reported Outcome for Systemic Lupus Erythematosus
Meenakshi Jolly¹, Nisarg Gandhi², Alana Nevares³ and Winston Sequeira², ¹Department of Medicine, Section of Rheumatology, Rush University Medical Center, Chicago, IL, ²Rheumatology, Rush University Medical Center, Chicago, IL, ³Internal Medicine, Cook County Hospital, Chicago, IL
Background/Purpose: Disease Specific Patient reported outcome measure tools capture unique domains relevant to patients with a specific disease. LupusPRO is targeted towards measuring health (HRQOL)…
Abstract Number: 788 • 2015 ACR/ARHP Annual Meeting
Identification of Molecular Biomarkers to Distinguish Systemic Lupus Erythematosus with Skin Involvement from Discoid Lupus Erythematosus and Subacute Cutaneous Erythematosus: Provisional Results from Cross-Sectional Studies
Matteo Cesaroni¹, Jarrat Jordan¹, Jessica Schreiter¹, Marc Chevrier¹, Grace Wang², Cesar Calderon³, Alexa Piantone², Ian Gourley⁴, Stanley Cohen⁵, Scott Fretzin⁶, Anna Wozniacka⁷, Victoria P. Werth⁸ and Jacqueline Benson¹, ¹Estrela Lupus Venture, Janssen Research and Development, LLC., Spring House, PA, ²Janssen Research and Development, Spring House, PA, ³37 Derwen Dr., Janssen Research and Development, Havertown, PA, ⁴1329 Anthony Wayne drive, Janssen Research and Development, Wayne, PA, ⁵Metroplex Clinical Research Center, LLC, Dallas, TX, ⁶Dawes Fretzin Clinical Research Group, LLCC, Indianapolis, IN, ⁷Medical University of Lodz, Lodz, Poland, ⁸Philadelphia VA Medical Center, Philadelphia, PA
Background/Purpose: Sub-classification of Lupus Erythematosus (LE) patients is largely based on defined clinical criteria while biological factors associating with or contributing to these clinical features…
Abstract Number: 789 • 2015 ACR/ARHP Annual Meeting
Direct Coombs Positivity in SLE
Nour Abou Assalie¹, Wei Fu² and Michelle Petri³, ¹Saint Agnes Hospital, Baltimore, MD, ²Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ³Johns Hopkins University School of Medicine, Baltimore, MD
Background/Purpose: The Coombs test is now one of the SLICC classification criteria for SLE classification. We investigated the association of the Coombs test with other…
Abstract Number: 790 • 2015 ACR/ARHP Annual Meeting
An Intervention to Improve Quality of Life for African-American Lupus Patients
Edith M. Williams¹, Johnese Bostic², Alyssa Adkins³, Larisa Bruner², Jiajia Zhang², Diane L. Kamen⁴ and Jim Oates⁴, ¹Institute for Partnerships to Eliminate Health Disparities, University of South Carolina, Columbia, SC, ²University of South Carolina, Columbia, SC, ³University of South Carolina, Greenville, SC, ⁴Medicine, Medical University of South Carolina, Charleston, SC
Background/Purpose: The Intervention to Improve Quality of life for African-AmericaN lupus patients (IQAN) Project is designed to examine whether a uniquely tailored intervention program can…
Abstract Number: 791 • 2015 ACR/ARHP Annual Meeting
Impact of Online Education and Social Media Intervetion for Self-Management in Adolescents with SLE
Lisabeth Scalzi¹ and Nancy J. Olsen², ¹Internal Medicine andPediatrics, Hershey Medical Center, Hershey, PA, ²Divsion of Rheumatology, Department of Medicine, Penn State MS Hershey Medical Center, Hershey, PA
Background/Purpose: Self-management (SM) skills are vital to the physical and emotional health adolescents with systemic lupus erythematosus (SLE). These self-management skills may also affect successful…
Abstract Number: 792 • 2015 ACR/ARHP Annual Meeting
Incidence and Persistence of Cervical Human Papillomavirus Infection in Mexican Systemic Lupus Erythematosus Women
Claudia Mendoza Pinto¹, Mario García-Carrasco^2,3, Verónica Vallejo-Ruiz⁴, Socorro Méndez-Martínez⁵, Alejandro Taboada-Cole⁶, José Luis Totolhua Ramírez⁷, Julio Reyes-Leyva⁴ and Aurelio López-Colombo⁸, ¹Systemic Autoimmune Diseases Research Unit, HGR 36-CIBIOR, Instituto Mexicano del Seguro Social, Puebla, Mexico, ²Systemic Autoimmune Diseases Research Unit, HGR 36-CIBIOR Instituto Mexicano del Seguro Social, Puebla, Mexico, ³Inmunología y Reumatología, Universidad Autónoma de Puebla, Puebla, Mexico, ⁴Molecular Biology and Virology Laboratory, CIBIOR, Instituto Mexicano del Seguro Social, Puebla, Mexico, ⁵Research Coordination Delegation, Instituto Mexicano del Seguro Social, Puebla, Mexico, ⁶Systemic Autoimmune Disease Research Unit, HGR 36, Instituto Mexicano del Seguro Social, Puebla, Mexico, ⁷Department of Pathology, HGR 36, Instituto Mexicano del Seguro Social, Puebla, Mexico, ⁸State Research and Education Department, UMAE,Hospital de Especialidades, Instituto Mexicano del Seguro Social, Puebla, Mexico
Background/Purpose: The risk of high-grade squamous intraepithelial lesions is significantly increased in SLE patients compared with healthy female controls. High-risk human papillomavirus infection (HR-HPV) is…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].